A new bill introduced in the Utah Legislature seeks to create a study of certain medications that are prescribed to transgender youth in order to help them transition.
The bill, sponsored by Rep. Brad Daw (R-Orem), would create such a study, and direct it to “conduct a review of any available scientific research related to the administration of a gonadotropin releasing hormone agent to a minor for the purpose of facilitating the minor’s desire to present or appear in a manner that is inconsistent with the minor’s sex, and any side effects of that use.”
Daw, told Salt Lake City’s FOX 13 in a text message that in investigating the topic of minors who undergo a gender transition, he became concerned about the short-term and long-term side effects of puberty blockers that are used to assist in a transition.
“I believe that having the state take a closer at this is worth doing,” Daw said.
If approved, the bill would require any information about transition-related medications to be submitted by November to the Utah State Legislature’s Health and Human Services Committee.
The doctor in charge of running the study would be required to have a degree in medicine, pharmacology or a related field, according to the bill.
Opponents of the bill worry that the study may be used by opponents of transgender rights to propose more sweeping bills — similar to those introduced in other states this year — to restrict minors’ ability to access to hormones or puberty blockers by punishing prescribers.
“It’s a much better bill in terms of not trying to restrict people’s access,” Candice Metzler, the director of Transgender Education Advocates of Utah, told FOX 13 when comparing it to legislation in other states.
But Metzler said her group still does not support the bill, arguing that there is already government-funded and peer-reviewed research on the subject that is easy enough for lawmakers to access if they so wish.
She also objects to language in the bill referring to a minor’s biological sex.
“Sex is not what people identify with,” said Metzler. “I just think part of the problem is the language further complicates things and it does leave questions about what the purpose of the study is.”
The U.S. House of Representatives passed an annual defense funding bill that contains a provision prohibiting coverage of gender-affirming medical care.
The House voted 281-140 to pass the bill, with 81 Democrats siding with Republicans. Sixteen Republicans voted against passage of the bill, primarily due to objections not having to do with the transgender care ban.
Under the provision, TriCare, the military's health insurance plan, is banned from covering any medical treatment for "gender dysphoria that could result in sterilization" for minor dependents of military members.
Wes Streeting, the United Kingdom's health secretary, recently announced that puberty blockers will be indefinitely banned for all people under age 18.
The Department of Health and Social Care said the Commission on Human Medicines had published independent expert advice that there was "currently an unacceptable safety risk in the continued prescription of puberty blockers to children," reported The Guardian.
The Labour government's ban on puberty blockers will apply to transgender patients in England, Scotland, Wales, and Northern Ireland. Cisgender children who are experiencing precocious puberty or early-onset puberty will continue to be allowed to access puberty blockers.
The Montana Supreme Court upheld a temporary injunction blocking the state from enforcing its ban on gender-affirming care for transgender youth.
The unanimous ruling is historic, marking the first time that a state Supreme Court has found that a ban on gender-affirming care is likely unconstitutional.
On December 11, the court ruled that SB 99, a 2023 law categorically banning all transition-related medical interventions on minors, violates the Montana State Constitution's privacy clause, which prohibits the government from interfering with private medical decisions.
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.